Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
David Clouston
Affiliation
ORCID
Career Start Year
1995
Papers
57
H Index
24
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37100665
Signet ring stromal tumours of testis: a tale of two cases on a morphological spectrum.
Pathology
2023
37208678
Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival.
BMC Cancer
2023
34687792
Hidden clues in prostate cancer - Lessons learned from clinical and pre-clinical approaches on diagnosis and risk stratification.
Cancer Lett
2022
35764368
Tumor immune microenvironment of primary prostate cancer with and without germline mutations in homologous recombination repair genes.
J Immunother Cancer
2022
36270849
LOT and HOT ⿦ or not. The proliferation of clinically insignificant and poorly characterised types of renal neoplasia.
Pathology
2022
35892882
Novel Germline Mutations in a Cohort of Men with Familial Prostate Cancer.
Cancers (Basel)
2022
35950036
Cribriform pattern disease over-represented in pelvic lymph node metastases identified on <sup>68</sup>GA PSMA-PET/CT.
BJUI Compass
2022
34949766
Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients.
Mod Pathol
2022
34784097
Neuroendocrine cells in prostate cancer correlate with poor outcomes: a systematic review and meta-analysis.
BJU Int
2022
34232604
SP142 PD-L1 Scoring Shows High Interobserver and Intraobserver Agreement in Triple-negative Breast Carcinoma But Overall Low Percentage Agreement With Other PD-L1 Clones SP263 and 22C3.
Am J Surg Pathol
2021
33620092
Androgen receptor enhancer amplification in matched patient-derived xenografts of primary and castrate-resistant prostate cancer.
J Pathol
2021
34413304
The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology.
Nat Commun
2021
32132214
Knowing what's growing: Why ductal and intraductal prostate cancer matter.
Sci Transl Med
2020
31843189
Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded.
Pathology
2020
30930118
Intraclonal Plasticity in Mammary Tumors Revealed through Large-Scale Single-Cell Resolution 3D Imaging.
Cancer Cell
2019
31185217
Intraclonal Plasticity in Mammary Tumors Revealed through Large-Scale Single-Cell Resolution 3D Imaging.
Cancer Cell
2019
31212368
Establishing a cryopreservation protocol for patient-derived xenografts of prostate cancer.
Prostate
2019
31279442
Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation.
Pathology
2019
28977728
Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate-tolerant cells.
BJU Int
2018
30049486
Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy.
Eur Urol
2018
29680797
Xp11 translocation renal cell carcinoma paraneoplastic syndrome presenting as cutaneous vasculitis: first reported case of yet another mask.
BMJ Case Rep
2018
29344954
Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology.
J Pathol
2018
29119638
Biphasic papillary renal cell carcinoma is a rare morphological variant with frequent multifocality: a study of 28 cases.
Histopathology
2018
28067867
Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories.
Nat Commun
2017
28342640
Systematic Review Links the Prevalence of Intraductal Carcinoma of the Prostate to Prostate Cancer Risk Categories.
Eur Urol
2017
27014658
Incidental prostate cancer in transurethral resection of prostate specimens in men aged up to 65 years.
Prostate Int
2016
26534844
Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families.
J Med Genet
2016
26585945
Searching for candidate genes in familial BRCAX mutation carriers with prostate cancer.
Urol Oncol
2016
27995114
Gleason group concordance between biopsy and radical prostatectomy specimens: A cohort study from Prostate Cancer Outcome Registry - Victoria.
Prostate Int
2016
27095381
Management of Early Node-Positive Breast Cancer in Australia: A Multicentre Study.
Breast J
2016
24784491
Altered significance of D'Amico risk classification in patients with prostate cancer linked to a familial breast cancer (kConFab) cohort.
BJU Int
2015
25864171
Comparison of [(11)C]choline Positron Emission Tomography With T2- and Diffusion-Weighted Magnetic Resonance Imaging for Delineating Malignant Intraprostatic Lesions.
Int J Radiat Oncol Biol Phys
2015
25154392
Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis.
Eur Urol
2015
24192979
Diffusion-weighted MRI, 11C-choline PET and 18F-fluorodeoxyglucose PET for predicting the Gleason score in prostate carcinoma.
Eur Radiol
2014
25263387
Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists.
Ann Diagn Pathol
2014
24053510
Comparison of contemporary methods for estimating prostate tumour volume in pathological specimens.
BJU Int
2014
24127673
Metaplastic conditions of the bladder.
BJU Int
2013
22658218
Intensity modulated radiation therapy dose painting for localized prostate cancer using ¹¹C-choline positron emission tomography scans.
Int J Radiat Oncol Biol Phys
2012
23194119
In situ and intraductal epithelial proliferations of prostate: definitions and treatment implications. Part 2: intraductal carcinoma and ductal adenocarcinoma of prostate.
BJU Int
2012
23035815
High grade prostatic intraepithelial neoplasia does not display loss of heterozygosity at the mutation locus in BRCA2 mutation carriers with aggressive prostate cancer.
BJU Int
2012
22458488
In situ and intraductal epithelial proliferations of prostate: definitions and treatment implications. Part 1: Prostatic intraepithelial neoplasia.
BJU Int
2012
21733824
Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families.
Cancer Prev Res (Phila)
2011
22085120
Penile lichen sclerosus (balanitis xerotica obliterans).
BJU Int
2011
21600669
Histopathological correlation of (11)C-choline PET scans for target volume definition in radical prostate radiotherapy.
Radiother Oncol
2011
21716159
Prognostic factors in prostate cancer. Key elements in structured histopathology reporting of radical prostatectomy specimens.
Pathology
2011
19651608
CT-X antigen expression in human breast cancer.
Proc Natl Acad Sci U S A
2009
17924939
Transitional cell carcinoma in the paediatric population: be aware of unusual aetiologies.
J Paediatr Child Health
2007
11865070
Binding of the RING polycomb proteins to specific target genes in complex with the grainyhead-like family of developmental transcription factors.
Mol Cell Biol
2002
12121169
Autoimmune pancreatitis.
ANZ J Surg
2002
10995745
Targeted disruption of the CP2 gene, a member of the NTF family of transcription factors.
J Biol Chem
2001
1 - 50 of 57
Column Actions
Search
Recommended Authors
Simpa S Salami
University of Michigan Medical School ann arbor
Career Start Year
2012
Number of shared co-authors
2
Steven Hazell
Royal Marsden NHS Foundation Trust
Career Start Year
2011
Number of shared co-authors
4
Brian D Robinson
Sandra and Edward Meyer Cancer Center
Career Start Year
2008
Number of shared co-authors
9
Roula Albadine
Centre hospitalier de l'Universite de Montreal
Career Start Year
2006
Number of shared co-authors
5
Michelle R Downes
University of Toronto
Career Start Year
2006
Number of shared co-authors
8
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year
2005
Number of shared co-authors
7
Huihui Ye
College of Optical Science and Engineering, Zhejiang University
Career Start Year
2004
Number of shared co-authors
6
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year
2003
Number of shared co-authors
10
Mathieu Latour
Centre Hospitalier de l'Universite de Montreal
Career Start Year
2001
Number of shared co-authors
11
Rohit Mehra
Michigan Center for Translational Pathology.
Career Start Year
2000
Number of shared co-authors
12
Anuradha Gopalan
Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center
Career Start Year
2000
Number of shared co-authors
11
Jiaoti Huang
Duke University School of Medicine
Career Start Year
2000
Number of shared co-authors
10
Geert J L H van Leenders
Erasmus MC Cancer Institute, University Medical Center
Career Start Year
1998
Number of shared co-authors
21
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year
1997
Number of shared co-authors
10
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year
1994
Number of shared co-authors
5
Bhaskar Kallakury
Georgetown University
Career Start Year
1993
Number of shared co-authors
0
Raymond S Lance
Washington State University Elson S. Floyd College of Medicine
Career Start Year
1992
Number of shared co-authors
4
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year
1991
Number of shared co-authors
5
Mark A Rubin
University of Bern
Career Start Year
1990
Number of shared co-authors
22
Madeleine Moussa
Schulich School of Medicine and Dentistry, University of Western Ontario
Career Start Year
1989
Number of shared co-authors
6
Bernd Wullich
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Career Start Year
1989
Number of shared co-authors
4
Freddie C Hamdy
University of Oxford
Career Start Year
1987
Number of shared co-authors
11
Armen Aprikian
McGill University Health Centre, McGill University
Career Start Year
1987
Number of shared co-authors
9
Edward C Jones
University of British Columbia
Career Start Year
1985
Number of shared co-authors
9
Dominique Trudel
Institut du cancer de Montreal
Career Start Year
1985
Number of shared co-authors
19
Eric A Klein
Cleveland Clinic
Career Start Year
1984
Number of shared co-authors
11
Victor E Reuter
Memorial Sloan Kettering Cancer Center
Career Start Year
1983
Number of shared co-authors
20
David M Berman
Queen's University
Career Start Year
1982
Number of shared co-authors
12
Cathy Corbishley
The Institute of Cancer Research
Career Start Year
1977
Number of shared co-authors
6
Daniel M Berney
Barts Cancer Institute, Queen Mary University of London
Career Start Year
1975
Number of shared co-authors
15
row(s) 1 - 30 of 30
Collaborators
Damien Bolton
University of Melbourne
Co-authored papers
20
Renea A Taylor
Peter MacCallum Cancer Centre
Co-authored papers
13
Gail P Risbridger
Biomedicine Discovery Institute, Monash University
Co-authored papers
12
Heather Thorne
Peter MacCallum Cancer Centre
Co-authored papers
12
Declan G Murphy
Peter MacCallum Cancer Centre, University of Melbourne
Co-authored papers
10
Mark Frydenberg
Monash University
Co-authored papers
9
Mitchell G Lawrence
Biomedicine Discovery Institute, Monash University
Co-authored papers
9
Melissa Papargiris
Biomedicine Discovery Institute, Monash University
Co-authored papers
6
Lars Egevad
Karolinska Institute
Co-authored papers
5
Vincent Khoo
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Co-authored papers
4
Gillian Mitchell
Familial Cancer Centre Peter MacCallum Cancer Centre Parkville Victoria 0 Australia.
Co-authored papers
4
Holger Moch
University Hospital Zurich
Co-authored papers
3
Ania Sliwinski
The Sir Peter MacCallum Department of Oncology University of Melbourne
Co-authored papers
3
Andrew J Evans
Princess Margaret Cancer Center, University Health Network.
Co-authored papers
3
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers
3
John R Srigley
University of Toronto
Co-authored papers
3
Sunil R Lakhani
University of Queensland
Co-authored papers
3
Abbas Agaimy
Institute of Pathology, Friedrich-Alexander University Erlangen-Nurnberg (FAU)
Co-authored papers
2
Leonard Da Silva
Pathology Queensland The Royal Brisbane and Women's Hospital Brisbane Qld Australia.
Co-authored papers
2
Richard O'Sullivan
Co-authored papers
2
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers
2
Ian G Campbell
Co-authored papers
2
Fadi Brimo
McGill University Health Centre, McGill University
Co-authored papers
2
Arun A Azad
Peter MacCallum Cancer Centre
Co-authored papers
2
Gordon K Smyth
The University of Melbourne
Co-authored papers
2
Otavia L Caballero
Ludwig Institute for Cancer Research Ltd.
Co-authored papers
1
Katia Nones
QIMR Berghofer Medical Research Institute
Co-authored papers
1
James W Denham
University of Newcastle
Co-authored papers
1
Md Nazmul Karim
Co-authored papers
1
Kara L Britt
Co-authored papers
1
1 - 30